/
/
/

Alembic Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)808.00
Volume (₹)1.71 L
High (₹)828.10
Upper Circuit969.80
Low (₹)797.40
Lower Circuit646.60
Prev Close808.20
52W High (₹)998.00
Price799.55
52W Low (₹)635.80

Share Market Cap & Key Ratios Overview

M.Cap (₹)15878.40 Cr
Div. Yield (%)1.49
PE Ratio22.90
Debt to Equity0.24
Price to Book2.29
Book Value288.72
EPS (TTM)35.28
Face Value2.00
ROE (%)12.35

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
CIPLANSE
ZYDUSLIFENSE
LAURUSLABSNSE
LUPINNSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
APLLTDNSE
LTP
1W Low
1W High
Market cap (₹)
1895-36.7 (-1.90%)
1883.10
1936.80
4,55,634Cr
9315+95 (1.03%)
9100
9315
2,41,576Cr
4914-98 (-1.96%)
4823
5025
1,84,478Cr
1395-17.8 (-1.26%)
1375.50
1415.40
1,11,888Cr
1156.9+2.7 (0.23%)
1114.10
1163
1,11,820Cr
1876.7+12.7 (0.68%)
1832.70
1876.70
99,418Cr
2105-50.2 (-2.33%)
2095.60
2159.90
96,529Cr
1144.2-12.3 (-1.06%)
1141.80
1166.80
96,322Cr
2318-73.5 (-3.07%)
2303.50
2390
96,180Cr
1660+11.8 (0.72%)
1622.60
1668
95,127Cr
799.55-27.35 (-3.31%)
792.60
833.50
15,878Cr

Key Highlights of Alembic Pharmaceuticals Ltd Balance Sheet

Alembic Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹39.31Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹39.31Cr, and the reserves and surplus of the company is ₹5575.95Cr.

The company has its non-current liabilities with total liabilities of ₹8040.45Cr as of 2026-03-31.

The current liabilities are ₹2425.02Cr as of 2026-03-31. At the same time, current assets are ₹4069.87Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹271.4Cr and tangible assets of ₹2828.42Cr, provided in the Alembic Pharmaceuticals Ltd financial statements.